Consider two treatments for lung cancer:
(1) radiation and chemotherapy and (2) immunotherapy.
Treatment 1 costs $30,000. Treatment 2 costs $75,000. With treatment 1, there is a 75% chance the patient will be alive in year 1 and a 50% chance in year 2, but the patient will die in year 3. The quality of life is poor with treatment 1, 50% of full health in both years. With treatment 2, there is 50% chance of being alive in year 1 and a 40% chance of being alive in year 2, and a 30% chance of being alive in year 3 and the patient will be dead in year 4. However, the quality of life is much better: 90% of full health in years 1, 2, and 3. The discount rate is 5%.
a. How many QALY’s will each treatment yield?
b. Use the given costs and your answer to part a) to calculate the Incremental Cost Effectiveness Ratio (ICER) for the two treatments.
c. Based on what you know about the value of statistical life (VSL), does the more expensive treatment seem reasonably cost-effective? Explain.





Consider two treatments for lung cancer: (1) radiation and chemotherapy and (2) immunotherapy. Treatment 1 costs...
The following information has been gathered on the costs and effectiveness of the two treatments, A and B. In this problem, costs and consequences are not discounted. Treatment A Treatment B Mortality rate 2% 5% Life expectancy for survivors 30 years 20 years Initial treatment cost $20,000 $10,000 Follow up costs, year 1 $5,000 $1,000 Annual follow up costs, all subsequent years $1,000 $500 Calculate the incremental cost and incremental benefit of the treatment alternatives. DC = DE = What...
The following information has been gathered on the costs and effectiveness of the two treatments, A and B. In this problem, costs and consequences are not discounted. Treatment A Treatment B Mortality rate 2% 5% Life expectancy for survivors 30 years 20 years Initial treatment cost $20,000 $10,000 Follow up costs, year 1 $5,000 $1,000 Annual follow up costs, all subsequent years $1,000 $500 a. What is the total cost for the survivors receiving treatment A? $54,000 For decedents (assuming...
Question 2 3 pts A 73 year old female with lung cancer has been receiving chemotherapy. She completed her third treatment 5 days ago and has been experiencing nausea & vomiting for 2 days. She is admitted to the hospital and the nurse performs an assessment. Subjective data: Patient reports lethargy, weakness, dizziness, & dry mouth. States too nauseated to eat or drink for 2 days Objective Data: Heart rate 110 beats per minute (normal is 60-100) Blood pressure 90/65...
Please help ASAP. A new treatment has been developed to alleviate the symptoms of Hansen’s disease (once known as Leprosy), which is prevalent on Island Z. The treatment does not eliminate all symptoms but substantially reduces their severity. All of those with the disease had been advised to take a one-time treatment that costs $5,000 (Treatment A). However a new treatment has come on the market. It is also taken one time, but like many drugs with a small market...
explain the table 1 and figure 2. what question is being asked and
table 1 and figure 2.
Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis TABLE 1 Base-Case Estimates of Cost, OALYS, and incremental Cost-Effectiveness with 10-Year Time Horizon Cost $ QALYS ICER, S/QALY ICER vs. Etanercept, S/QALY No treatment 00.451 5531 - N/A N/A Apremilast 137,080 6.403 81,033 (vs. no treatment NA Etanercept 1887 6.505 433 248 Vs apremilast N/A Adalimumab 194.180 6681 72.703 vs tanercepe...
2. Ms. Williams underwent a lobectomy for lung cancer 6 months ago, followed by treatment with radiation therapy and chemotherapy. On her most recent visit to the oncologist, she is told that despite the treatments, there is evidence of metastatic disease in her spine. The physician explains that there are no further treatment options, and refers Ms. Rogers to Hospice for continuing care. a. What are the underlying principles of hospice? b. To be eligible for Medicare and Medicaid Hospice...
You have the following table of costs and benefits for alternative treatments Treatment # Cost Effectiveness (life years gained) 1 100000 5 2 200000 3 3 400000 10 4 500000 20 A. Which treatment(s) if any, is strongly dominated? B. Which treatment(s) if any is weakly dominated? C. Calculate incremental cost effectiveness ratios. D. Assuming that a life year is considered to be worth up to 100000, which interventions would you choose, in the absence of budgetary constraints? E. How might budgetary constraints affect your...
Consider the following costs and benefits associated with two treatments, A and B. Costs and benefits are in dollars Costs Treatment Yr 1 Yr2 Yr3 A 100 700 400 B 400 300 200 Benefits Treatment Yr 1 Yr2 Yr3 A 300 400 900 B 500 600 100 A. Assuming a discount rate of 5% and no discounting applied in Yr 1, calculate the present value of net benefits for each treatment. Ans. B. If the treatments are stopped after Yr 2, which...
Economic Evaluation problem 1 The following information has been gathered on the costs and effectiveness of the two treatments, A and B. In ths prodle, eSts and consequences are not discounted. Treatment A 2% 20 years $10,000 $5,000 Annual follow up costs, all $1,000 Treatment B Mortality rate Life expectancy for survivors Initial treatment cost 5% 10 years $3,000 Follow up costs, year 1 $1,000 $500 subsequent years 31,O00 11000 b. What is the total cost for survivors receiving treatment...
2.Cost-effectiveness Analysis Amoria Phlebitis is a fictional illness from The Simpsons that causes sharp stabbing pains to the stomach and arms and temporary loss of vision. A 25-year-old patient diagnosed with this condition has an expected lifespan of 35 more years, during which they will continue to deal with these symptoms. Two new treatments (surgery and medication) have recently been proposed as alternatives to the current solution (no treatment). Medication prevents the disease from getting worse and will extend the...